221 related articles for article (PubMed ID: 25824049)
1. MiR-520b suppresses proliferation of hepatoma cells through targeting ten-eleven translocation 1 (TET1) mRNA.
Zhang W; Lu Z; Gao Y; Ye L; Song T; Zhang X
Biochem Biophys Res Commun; 2015 May; 460(3):793-8. PubMed ID: 25824049
[TBL] [Abstract][Full Text] [Related]
2. MiR-506 suppresses liver cancer angiogenesis through targeting sphingosine kinase 1 (SPHK1) mRNA.
Lu Z; Zhang W; Gao S; Jiang Q; Xiao Z; Ye L; Zhang X
Biochem Biophys Res Commun; 2015 Dec 4-11; 468(1-2):8-13. PubMed ID: 26549227
[TBL] [Abstract][Full Text] [Related]
3. MiR-30e suppresses proliferation of hepatoma cells via targeting prolyl 4-hydroxylase subunit alpha-1 (P4HA1) mRNA.
Feng G; Shi H; Li J; Yang Z; Fang R; Ye L; Zhang W; Zhang X
Biochem Biophys Res Commun; 2016 Apr; 472(3):516-22. PubMed ID: 26966067
[TBL] [Abstract][Full Text] [Related]
4. MicroRNA-494 is a master epigenetic regulator of multiple invasion-suppressor microRNAs by targeting ten eleven translocation 1 in invasive human hepatocellular carcinoma tumors.
Chuang KH; Whitney-Miller CL; Chu CY; Zhou Z; Dokus MK; Schmit S; Barry CT
Hepatology; 2015 Aug; 62(2):466-80. PubMed ID: 25820676
[TBL] [Abstract][Full Text] [Related]
5. MiR-107 suppresses proliferation of hepatoma cells through targeting HMGA2 mRNA 3'UTR.
Wang Y; Chen F; Zhao M; Yang Z; Zhang S; Ye L; Gao H; Zhang X
Biochem Biophys Res Commun; 2016 Nov; 480(3):455-460. PubMed ID: 27773820
[TBL] [Abstract][Full Text] [Related]
6. MiR-205 modulates abnormal lipid metabolism of hepatoma cells via targeting acyl-CoA synthetase long-chain family member 1 (ACSL1) mRNA.
Cui M; Wang Y; Sun B; Xiao Z; Ye L; Zhang X
Biochem Biophys Res Commun; 2014 Feb; 444(2):270-5. PubMed ID: 24462768
[TBL] [Abstract][Full Text] [Related]
7. miR-511 promotes the proliferation of human hepatoma cells by targeting the 3'UTR of B cell translocation gene 1 (BTG1) mRNA.
Zhang SQ; Yang Z; Cai XL; Zhao M; Sun MM; Li J; Feng GX; Feng JY; Ye LH; Niu JQ; Zhang XD
Acta Pharmacol Sin; 2017 Aug; 38(8):1161-1170. PubMed ID: 28603285
[TBL] [Abstract][Full Text] [Related]
8. Hepatitis B virus X protein accelerates hepatocarcinogenesis with partner survivin through modulating miR-520b and HBXIP.
Zhang W; Lu Z; Kong G; Gao Y; Wang T; Wang Q; Cai N; Wang H; Liu F; Ye L; Zhang X
Mol Cancer; 2014 May; 13():128. PubMed ID: 24886421
[TBL] [Abstract][Full Text] [Related]
9. MicroRNA-520e suppresses growth of hepatoma cells by targeting the NF-κB-inducing kinase (NIK).
Zhang S; Shan C; Kong G; Du Y; Ye L; Zhang X
Oncogene; 2012 Aug; 31(31):3607-20. PubMed ID: 22105365
[TBL] [Abstract][Full Text] [Related]
10. MicroRNA-520b inhibits growth of hepatoma cells by targeting MEKK2 and cyclin D1.
Zhang W; Kong G; Zhang J; Wang T; Ye L; Zhang X
PLoS One; 2012; 7(2):e31450. PubMed ID: 22319632
[TBL] [Abstract][Full Text] [Related]
11. Hepatitis B virus X protein mutant HBxΔ127 promotes proliferation of hepatoma cells through up-regulating miR-215 targeting PTPRT.
Liu F; You X; Chi X; Wang T; Ye L; Niu J; Zhang X
Biochem Biophys Res Commun; 2014 Feb; 444(2):128-34. PubMed ID: 24434140
[TBL] [Abstract][Full Text] [Related]
12. miR-202 suppresses cell proliferation in human hepatocellular carcinoma by downregulating LRP6 post-transcriptionally.
Zhang Y; Zheng D; Xiong Y; Xue C; Chen G; Yan B; Ye Q
FEBS Lett; 2014 May; 588(10):1913-20. PubMed ID: 24704686
[TBL] [Abstract][Full Text] [Related]
13. MiR-506 suppresses proliferation of hepatoma cells through targeting YAP mRNA 3'UTR.
Wang Y; Cui M; Sun BD; Liu FB; Zhang XD; Ye LH
Acta Pharmacol Sin; 2014 Sep; 35(9):1207-14. PubMed ID: 25087998
[TBL] [Abstract][Full Text] [Related]
14. MicroRNA-101 inhibits human hepatocellular carcinoma progression through EZH2 downregulation and increased cytostatic drug sensitivity.
Xu L; Beckebaum S; Iacob S; Wu G; Kaiser GM; Radtke A; Liu C; Kabar I; Schmidt HH; Zhang X; Lu M; Cicinnati VR
J Hepatol; 2014 Mar; 60(3):590-8. PubMed ID: 24211739
[TBL] [Abstract][Full Text] [Related]
15. Involvement of cholesterol in hepatitis B virus X protein-induced abnormal lipid metabolism of hepatoma cells via up-regulating miR-205-targeted ACSL4.
Cui M; Xiao Z; Sun B; Wang Y; Zheng M; Ye L; Zhang X
Biochem Biophys Res Commun; 2014 Mar; 445(3):651-5. PubMed ID: 24576478
[TBL] [Abstract][Full Text] [Related]
16. miR-615-5p is restrictedly expressed in cirrhotic and cancerous liver tissues and its overexpression alleviates the tumorigenic effects in hepatocellular carcinoma.
El Tayebi HM; Hosny KA; Esmat G; Breuhahn K; Abdelaziz AI
FEBS Lett; 2012 Sep; 586(19):3309-16. PubMed ID: 22819824
[TBL] [Abstract][Full Text] [Related]
17. BACH1 is transcriptionally inhibited by TET1 in hepatocellular carcinoma in a microRNA-34a-dependent manner to regulate autophagy and inflammation.
Sun X; Zhu H; Cao R; Zhang J; Wang X
Pharmacol Res; 2021 Jul; 169():105611. PubMed ID: 33878446
[TBL] [Abstract][Full Text] [Related]
18. MiR-365a-3p suppresses proliferation and invasion of Hep-2 cells through targeting ten-eleven translocation 1 (TET1).
Li J; Shen N; Bai GP; Huang XS
Neoplasma; 2018 Sep; 65(5):730-735. PubMed ID: 30249104
[TBL] [Abstract][Full Text] [Related]
19. miR-451 inhibits cell proliferation in human hepatocellular carcinoma through direct suppression of IKK-β.
Li HP; Zeng XC; Zhang B; Long JT; Zhou B; Tan GS; Zeng WX; Chen W; Yang JY
Carcinogenesis; 2013 Nov; 34(11):2443-51. PubMed ID: 23740840
[TBL] [Abstract][Full Text] [Related]
20. miR-217 suppresses proliferation, migration, and invasion promoting apoptosis via targeting MTDH in hepatocellular carcinoma.
Zhang M; Li M; Li N; Zhang Z; Liu N; Han X; Liu Q; Liao C
Oncol Rep; 2017 Mar; 37(3):1772-1778. PubMed ID: 28184926
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
